In August 2025, semaglutide (Wegovy) received FDA accelerated approval for MASH with F2 to F3 fibrosis based on the results of the ESSENCE trial
Translation: food sources can matter, especially when your overall diet supports digestion, absorption, and nutrient status
Given the proportions of missing data for eGFR, BMI and other variables (ESM Table 2), we used multiple imputations (Markov chain Monte Carlo method) to handle missing data
Supplement Timing Strategy Strategic supplement timing enhances absorption and minimizes side effects
An improved canine genome and a comprehensive catalogue of coding genes and non-coding transcripts
Real-World Observations: What We Know Today Current evidence for GLP-1 in binge eating disorder comes primarily from patient reports, small case series, and extrapolation from weight loss and eating behavior studies